Spondyloarthritis

Degree of bone marrow oedema in sacroiliac joints of patients with axial spondyloarthritis is linked to gut inflammation and male sex: results from the GIANT cohort
Liesbet Van Praet, Lennart Jans, Philippe Carron, Peggy Jacques, Elien Glorieus, Roos Colman, Heleen Cypers, Herman Mielants, Martine De Vos, Claude Cuvelier, Filip Van den Bosch, Dirk Elewaut

Annals of the Rheumatic Diseases Jun 2014, 73 (6) 1186-1189; DOI: 10.1136/annrheumdis-2013-203854
Autoantibodies against CD74 in spondyloarthritis
N T Baerlecken, S Nothdorft, G H Stummvoll, J Sieper, M Rudwaleit, S Reuter, T Matthias, R E Schmidt, T Witte

Annals of the Rheumatic Diseases Jun 2014, 73 (6) 1211-1214; DOI: 10.1136/annrheumdis-2012-202208
Senescence marker killer cell lectin-like receptor G1 (KLRG1) contributes to TNF-α production by interaction with its soluble E-cadherin ligand in chronically inflamed joints
Lode Melis, Liesbet Van Praet, Hanspeter Pircher, Koen Venken, Dirk Elewaut

Annals of the Rheumatic Diseases Jun 2014, 73 (6) 1223-1231; DOI: 10.1136/annrheumdis-2013-203881
Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials
Arthur Kavanaugh, Christopher Ritchlin, Proton Rahman, Lluis Puig, Alice B Gottlieb, Shu Li, Yuhua Wang, Lenore Noonan, Carrie Brodmerkel, Michael Song, Alan M Mendelsohn, Iain B McInnes, on behalf of the PSUMMIT-1 and 2 Study Groups

Annals of the Rheumatic Diseases Jun 2014, 73 (6) 1000-1006; DOI: 10.1136/annrheumdis-2013-204741
Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor
Arthur Kavanaugh, Philip J Mease, Juan J Gomez-Reino, Adewale O Adebajo, Jürgen Wollenhaupt, Dafna D Gladman, Eric Lespessailles, Stephen Hall, Marla Hochfeld, ChiaChi Hu, Douglas Hough, Randall M Stevens, Georg Schett

Annals of the Rheumatic Diseases Jun 2014, 73 (6) 1020-1026; DOI: 10.1136/annrheumdis-2013-205056
The effect of two golimumab doses on radiographic progression in ankylosing spondylitis: results through 4 years of the GO-RAISE trial
Jürgen Braun, Xenofon Baraliakos, Kay-Geert A Hermann, Atul Deodhar, Désirée van der Heijde, Robert Inman, Anna Beutler, Yiying Zhou, Stephen Xu, Benjamin Hsu

Annals of the Rheumatic Diseases Jun 2014, 73 (6) 1107-1113; DOI: 10.1136/annrheumdis-2012-203075
Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study
Gerd Horneff, Ruben Burgos-Vargas, Tamas Constantin, Ivan Foeldvari, Jelena Vojinovic, Vyacheslav G Chasnyk, Joke Dehoorne, Violeta Panaviene, Gordana Susic, Valda Stanevica, Katarzyna Kobusinska, Zbigniew Zuber, Richard Mouy, Ingrida Rumba-Rozenfelde, Luciana Breda, Pavla Dolezalova, Chantal Job-Deslandre, Nico Wulffraat, Daniel Alvarez, Chuanbo Zang, Joseph Wajdula, Deborah Woodworth, Bonnie Vlahos, Alberto Martini, Nicolino Ruperto, for the Paediatric Rheumatology International Trials Organisation (PRINTO)

Annals of the Rheumatic Diseases Jun 2014, 73 (6) 1114-1122; DOI: 10.1136/annrheumdis-2012-203046
Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial
Christopher Ritchlin, Proton Rahman, Arthur Kavanaugh, Iain B McInnes, Lluis Puig, Shu Li, Yuhua Wang, Yaung-Kaung Shen, Mittie K Doyle, Alan M Mendelsohn, Alice B Gottlieb, on behalf of the PSUMMIT 2 Study Group

Annals of the Rheumatic Diseases Jun 2014, 73 (6) 990-999; DOI: 10.1136/annrheumdis-2013-204655
The emerging problem of biological treatment in migrant and travelling populations: it is time to extend guidelines for the screening of infectious diseases
F Bartalesi, A Bartoloni, Z Bisoffi, M Spinicci, F Giménez Sánchez, J Muñoz, P Richi, G Minisola, S Muñoz-Fernandez, M Matucci-Cerinic

Annals of the Rheumatic Diseases May 2014, 73 (5) 794-796; DOI: 10.1136/annrheumdis-2013-203848
Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS)
Denis Poddubnyy, Kay-Geert A Hermann, Johanna Callhoff, Joachim Listing, Joachim Sieper

Annals of the Rheumatic Diseases May 2014, 73 (5) 817-823; DOI: 10.1136/annrheumdis-2013-204248

Main menu

Spondyloarthritis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Spondyloarthritis

Pages